Adia Nutrition transitioned to operational regenerative medicine with $700.5K revenue, achieving 27.4% gross margin, but incurred -$395.5K net loss and -$192.4K free cash flow due to scaling expenses outpacing topline amid funding needs.
Revenue breakdown: Sales Of Prducts And Services (53.7%), Sales Of Biologics (16.8%), Biologics (11%).
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment
No significant events in the past 90 days.